Cargando…

Neuropsychological measures of attention and memory function in schizophrenia: relationships with symptom dimensions and serum monoamine activity

BACKGROUND: Some clinical symptoms or cognitive functions have been related to the overall state of monoamine activity in patients with schizophrenia, (e.g. inverse correlation of the dopamine metabolite HVA with delusions or visual-masking performance). However, profiles (as presented here) of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Oades, Robert D, Röpcke, Bernd, Henning, Uwe, Klimke, Ansgard
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1208853/
https://www.ncbi.nlm.nih.gov/pubmed/16091141
http://dx.doi.org/10.1186/1744-9081-1-14
_version_ 1782124916091387904
author Oades, Robert D
Röpcke, Bernd
Henning, Uwe
Klimke, Ansgard
author_facet Oades, Robert D
Röpcke, Bernd
Henning, Uwe
Klimke, Ansgard
author_sort Oades, Robert D
collection PubMed
description BACKGROUND: Some clinical symptoms or cognitive functions have been related to the overall state of monoamine activity in patients with schizophrenia, (e.g. inverse correlation of the dopamine metabolite HVA with delusions or visual-masking performance). However, profiles (as presented here) of the relations of the activity of dopamine, noradrenaline and serotonin to neuropsychologic (dys)functions in major patient sub-groups with their very different symptomatic and cognitive characteristics have not been reported. METHODS: Serum measures of dopamine, noradrenaline and serotonin turnover were examined by regression analyses for the prediction of performance on 10 neuropsychological measures reflecting left- and right-hemispheric and frontal-, parietal- and temporal-lobe function in 108 patients with schizophrenia and 63 matched controls. The neuropsychological battery included tests of verbal fluency, Stroop interference, trail-making, block-design, Mooney faces recognition, picture-completion, immediate and delayed visual and verbal recall. Paranoid and nonparanoid subgroups were based on ratings from the Positive and Negative Syndrome Scale (PANSS). Groups with high and low ratings of ideas-of-reference and thought-disorder were formed from a median split on the Scale for Assessment of Positive Symptoms (SAPS). RESULTS: Verbal-fluency and Stroop-interference (left frontal and fronto-cingulate function) were negatively associated with noradrenergic turnover in nonparanoid and thought-disordered patients. High dopamine turnover related to speeded trail-making (frontal modulation of set switching) in those with many ideas-of-reference. In contrast, low dopamine turnover predicted poor recall in nonparanoid patients and those with little thought disorder. Serotonin metabolism did not independently contribute to the prediction any measure of cognitive performance. But, with regard to the relative activity between monoaminergic systems, increased HVA/5-HIAA ratios predicted visual-reproduction and Mooney's face-recognition performance (right-hemisphere functions) in highly symptomatic patients. Decreased HVA/MHPG predicted non-verbal recall. CONCLUSION: Clinical state and function are differentially sensitive to overall levels of monoamine activity. In particular, right-lateralised cerebral function was sensitive to the relative activities of the monoamines. Increased noradrenergic activity was associated with enhanced frontal but impaired temporal lobe function in nonparanoid syndromes. Low dopaminergic activity predicted poor attentional set control in those with ideas-of-reference, but poor recall in nonparanoid patients. These data, especially the HVA/5-HIAA ratios, provide a basis for planning the nature of antipsychotic treatment aimed at patient specific symptom dimensions and cognitive abilities.
format Text
id pubmed-1208853
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-12088532005-09-15 Neuropsychological measures of attention and memory function in schizophrenia: relationships with symptom dimensions and serum monoamine activity Oades, Robert D Röpcke, Bernd Henning, Uwe Klimke, Ansgard Behav Brain Funct Research BACKGROUND: Some clinical symptoms or cognitive functions have been related to the overall state of monoamine activity in patients with schizophrenia, (e.g. inverse correlation of the dopamine metabolite HVA with delusions or visual-masking performance). However, profiles (as presented here) of the relations of the activity of dopamine, noradrenaline and serotonin to neuropsychologic (dys)functions in major patient sub-groups with their very different symptomatic and cognitive characteristics have not been reported. METHODS: Serum measures of dopamine, noradrenaline and serotonin turnover were examined by regression analyses for the prediction of performance on 10 neuropsychological measures reflecting left- and right-hemispheric and frontal-, parietal- and temporal-lobe function in 108 patients with schizophrenia and 63 matched controls. The neuropsychological battery included tests of verbal fluency, Stroop interference, trail-making, block-design, Mooney faces recognition, picture-completion, immediate and delayed visual and verbal recall. Paranoid and nonparanoid subgroups were based on ratings from the Positive and Negative Syndrome Scale (PANSS). Groups with high and low ratings of ideas-of-reference and thought-disorder were formed from a median split on the Scale for Assessment of Positive Symptoms (SAPS). RESULTS: Verbal-fluency and Stroop-interference (left frontal and fronto-cingulate function) were negatively associated with noradrenergic turnover in nonparanoid and thought-disordered patients. High dopamine turnover related to speeded trail-making (frontal modulation of set switching) in those with many ideas-of-reference. In contrast, low dopamine turnover predicted poor recall in nonparanoid patients and those with little thought disorder. Serotonin metabolism did not independently contribute to the prediction any measure of cognitive performance. But, with regard to the relative activity between monoaminergic systems, increased HVA/5-HIAA ratios predicted visual-reproduction and Mooney's face-recognition performance (right-hemisphere functions) in highly symptomatic patients. Decreased HVA/MHPG predicted non-verbal recall. CONCLUSION: Clinical state and function are differentially sensitive to overall levels of monoamine activity. In particular, right-lateralised cerebral function was sensitive to the relative activities of the monoamines. Increased noradrenergic activity was associated with enhanced frontal but impaired temporal lobe function in nonparanoid syndromes. Low dopaminergic activity predicted poor attentional set control in those with ideas-of-reference, but poor recall in nonparanoid patients. These data, especially the HVA/5-HIAA ratios, provide a basis for planning the nature of antipsychotic treatment aimed at patient specific symptom dimensions and cognitive abilities. BioMed Central 2005-08-09 /pmc/articles/PMC1208853/ /pubmed/16091141 http://dx.doi.org/10.1186/1744-9081-1-14 Text en Copyright © 2005 Oades et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Oades, Robert D
Röpcke, Bernd
Henning, Uwe
Klimke, Ansgard
Neuropsychological measures of attention and memory function in schizophrenia: relationships with symptom dimensions and serum monoamine activity
title Neuropsychological measures of attention and memory function in schizophrenia: relationships with symptom dimensions and serum monoamine activity
title_full Neuropsychological measures of attention and memory function in schizophrenia: relationships with symptom dimensions and serum monoamine activity
title_fullStr Neuropsychological measures of attention and memory function in schizophrenia: relationships with symptom dimensions and serum monoamine activity
title_full_unstemmed Neuropsychological measures of attention and memory function in schizophrenia: relationships with symptom dimensions and serum monoamine activity
title_short Neuropsychological measures of attention and memory function in schizophrenia: relationships with symptom dimensions and serum monoamine activity
title_sort neuropsychological measures of attention and memory function in schizophrenia: relationships with symptom dimensions and serum monoamine activity
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1208853/
https://www.ncbi.nlm.nih.gov/pubmed/16091141
http://dx.doi.org/10.1186/1744-9081-1-14
work_keys_str_mv AT oadesrobertd neuropsychologicalmeasuresofattentionandmemoryfunctioninschizophreniarelationshipswithsymptomdimensionsandserummonoamineactivity
AT ropckebernd neuropsychologicalmeasuresofattentionandmemoryfunctioninschizophreniarelationshipswithsymptomdimensionsandserummonoamineactivity
AT henninguwe neuropsychologicalmeasuresofattentionandmemoryfunctioninschizophreniarelationshipswithsymptomdimensionsandserummonoamineactivity
AT klimkeansgard neuropsychologicalmeasuresofattentionandmemoryfunctioninschizophreniarelationshipswithsymptomdimensionsandserummonoamineactivity